2023 Early Hearing Detection & Intervention Conference
March 5-7, 2023 • Cincinnati, OH
<< BACK TO INSTRUCTIONAL SESSIONS
3/13/2022 | 1:00 PM - 3:30 PM | Medical Considerations in the Management of Pediatric Hearing Loss | Room 6
Medical Considerations in the Management of Pediatric Hearing Loss
The management of pediatric sensorineural hearing loss requires a coordinated team approach between a diverse group of professionals. These include audiologists, speech & language pathologists, early intervention specialists, physicians, educators, and many others. While the approaches and the details of the clinical algorithm vary dramatically across the country, the managing physician often plays a central role. The present workshop aims at detailing the physician’s perspective of the team approach by discussing various clinical scenarios applying the JCIH guidelines. This seems especially pertinent given the diverse clinical population served by hearing loss professionals. We also plan to detail imaging, surgical aspects in the management of pediatric hearing loss, established and new trends in cochlear implantation, and alternative technology.
- To detail the medical, family centered model for the management of pediatric hearing loss
- To review the medical work-up for pediatric hearing loss
- To review medical interventions for pediatric hearing loss
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Craig Buchman
(), Washington University, buchmanc@wustl.edu;
Dr. Buchman currently serves as the Chairman of the Department of Otolaryngology, Head & Neck Surgery at Washington University in St. Louis, Missouri.
He is a Neurotologist with extensive experience in pediatric cochlear implantation. Prior to his current position, he served as the division director at UNC where he oversaw the largest pediatric hearing program in the country. Further, he has published extensively in the field and serves as the Chairman of the Joint Commission (JCIH) on Infant Hearing and the past president of the American Cochlear Implant Alliance (ACIA)
ASHA DISCLOSURE:
Financial -
• Receives Honoraria excluding diversified mutual funds for Consulting from Advanced Bionics.
• Receives Ownership interest for Ownership from Advanced Cochlear Diagnostics, LLC.
• Receives Honoraria excluding diversified mutual funds for Consulting from Cochlear Corp..
• Receives Honoraria excluding diversified mutual funds for Consulting from Envoy.
• Receives Honoraria excluding diversified mutual funds for Consulting from IotaMotions, Inc..
Nonfinancial -
No relevant nonfinancial relationship exist.
Oliver Adunka
(), The Ohio State University, oadunka@mac.com;
Dr. Oliver F. Adunka is the division director of Otology, Neurotology, and Cranial Base Surgery at The Ohio State University in Columbus, OH. He is also the director of Pediatric Otology at Nationwide Children’s Hospital.
He earned his medical degree from the University of Vienna in Austria. He completed his otolaryngology residency training in at the Johann Wolfgang Goethe University in Frankfurt am Main, Germany. He subsequently subspecialized in otology, neurotology and lateral skull base surgery at the University of North Carolina.
His clinical practice includes all aspects of otology, neurotology, and lateral skull base surgery. Current and past research has focused on various aspects of cochlear implantation including clinical and experimental research on electrode insertion trauma, hearing preservation, and combined electric acoustic stimulation. He feels particularly passionate on many aspects of pediatric sensorineural hearing loss and pediatric cochlear implantation and hopes to provide a meaningful and lasting contribution to the field.
ASHA DISCLOSURE:
Financial -
• Receives Consulting fee,Royalty options or other ownership interest for Ownership from Advanced Bionics Corporation.
Nonfinancial -
No relevant nonfinancial relationship exist.